These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22397670)

  • 41. Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.
    Huls G; Mulder AB; Rosati S; van de Loosdrecht AA; Vellenga E; de Wolf JT
    Blood; 2010 Jul; 116(2):180-2. PubMed ID: 20194893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of calreticulin mutations in JAK2-negative polycythemia vera.
    Broséus J; Park JH; Carillo S; Hermouet S; Girodon F
    Blood; 2014 Dec; 124(26):3964-6. PubMed ID: 25305205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of the JAK2V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause.
    Strobbe L; Lestrade P; Hermans MH; Fijnheer R
    Ann Hematol; 2007 Nov; 86(11):801-3. PubMed ID: 17703302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation.
    Panovska-Stavridis I; Eftimov A; Ivanovski M; Pivkova-Veljanovska A; Cevreska L; Hermouet S; Dimovski AJ
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):e55-7. PubMed ID: 27009537
    [No Abstract]   [Full Text] [Related]  

  • 45. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.
    Wang SA; Hasserjian RP; Loew JM; Sechman EV; Jones D; Hao S; Liu Q; Zhao W; Mehdi M; Galili N; Woda B; Raza A
    Leukemia; 2006 Sep; 20(9):1641-4. PubMed ID: 16871284
    [No Abstract]   [Full Text] [Related]  

  • 46. Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations.
    Jeromin S; Haferlach T; Weissmann S; Meggendorfer M; Eder C; Nadarajah N; Alpermann T; Kohlmann A; Kern W; Haferlach C; Schnittger S
    Haematologica; 2015 Apr; 100(4):e125-7. PubMed ID: 25527566
    [No Abstract]   [Full Text] [Related]  

  • 47. Somatic and germline genetics at the JAK2 locus.
    Campbell PJ
    Nat Genet; 2009 Apr; 41(4):385-6. PubMed ID: 19338077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
    Szpurka H; Gondek LP; Mohan SR; Hsi ED; Theil KS; Maciejewski JP
    Leukemia; 2009 Mar; 23(3):610-4. PubMed ID: 18818701
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.
    Ziakas PD
    Haematologica; 2008 Sep; 93(9):1412-4. PubMed ID: 18641024
    [No Abstract]   [Full Text] [Related]  

  • 50. A novel germline JAK2 mutation in familial myeloproliferative neoplasms.
    Rumi E; Harutyunyan AS; Casetti I; Pietra D; Nivarthi H; Moriggl R; Cleary C; Bagienski K; Astori C; Bellini M; Berg T; Passamonti F; Kralovics R; Cazzola M
    Am J Hematol; 2014 Jan; 89(1):117-8. PubMed ID: 24142793
    [No Abstract]   [Full Text] [Related]  

  • 51. JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.
    Steensma DP; Tefferi A
    Blood; 2008 Feb; 111(3):1748. PubMed ID: 18223181
    [No Abstract]   [Full Text] [Related]  

  • 52. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Malcovati L; Della Porta MG; Pietra D; Boveri E; Pellagatti A; Gallì A; Travaglino E; Brisci A; Rumi E; Passamonti F; Invernizzi R; Cremonesi L; Boultwood J; Wainscoat JS; Hellström-Lindberg E; Cazzola M
    Blood; 2009 Oct; 114(17):3538-45. PubMed ID: 19692701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family.
    Liu K; Kralovics R; Rudzki Z; Grabowska B; Buser AS; Olcaydu D; Gisslinger H; Tiedt R; Frank P; Okoñ K; van der Maas AP; Skoda RC
    Haematologica; 2008 May; 93(5):706-14. PubMed ID: 18367486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Class prediction models of thrombocytosis using genetic biomarkers.
    Gnatenko DV; Zhu W; Xu X; Samuel ET; Monaghan M; Zarrabi MH; Kim C; Dhundale A; Bahou WF
    Blood; 2010 Jan; 115(1):7-14. PubMed ID: 19773543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plummer-Vinson syndrome and reactive thrombocytosis mask a JAK2-V617F positive myeloproliferative neoplasm.
    Scott EC; Schuster S
    Blood; 2011 Dec; 118(23):5988. PubMed ID: 22238785
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
    Passamonti F; Elena C; Schnittger S; Skoda RC; Green AR; Girodon F; Kiladjian JJ; McMullin MF; Ruggeri M; Besses C; Vannucchi AM; Lippert E; Gisslinger H; Rumi E; Lehmann T; Ortmann CA; Pietra D; Pascutto C; Haferlach T; Cazzola M
    Blood; 2011 Mar; 117(10):2813-6. PubMed ID: 21224469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis.
    Koppikar P; Abdel-Wahab O; Hedvat C; Marubayashi S; Patel J; Goel A; Kucine N; Gardner JR; Combs AP; Vaddi K; Haley PJ; Burn TC; Rupar M; Bromberg JF; Heaney ML; de Stanchina E; Fridman JS; Levine RL
    Blood; 2010 Apr; 115(14):2919-27. PubMed ID: 20154217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies.
    Veselovska J; Pospisilova D; Pekova S; Horvathova M; Solna R; Cmejlova J; Cmejla R; Belickova M; Mihal V; Stary J; Divoky V
    Leuk Res; 2008 Mar; 32(3):369-77. PubMed ID: 17719087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet RNA chips dip into thrombocytosis.
    Nagalla S; Bray PF
    Blood; 2010 Jan; 115(1):2-3. PubMed ID: 20056796
    [No Abstract]   [Full Text] [Related]  

  • 60. Familial chronic myeloproliferative disorders: the state of the art.
    Rumi E
    Hematol Oncol; 2008 Sep; 26(3):131-8. PubMed ID: 18484677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.